The peptide does not bind to a single identified receptor but instead modulates several biological systems simultaneously
To answer that, our content team reviewed more than 25 sources, including peer-reviewed studies, dermatology editorial content, and real user reports from Reddit and Substack diaries
Repeated intravesical injections of platelet-rich plasma are effective in the treatment of interstitial cystitis: a case control pilot study
(2010) transected the MCL in rats and treated with BPC-157 via three routes: local application, systemic intraperitoneal injection, and oral (in drinking water)
Dose selection in the research literature varies with the application: musculoskeletal-injury studies commonly report 200250 g twice daily near the affected site, while gastrointestinal-focused protocols use 250500 g once or twice daily, subcutaneously